| Primary |
| Renal Tuberculosis |
100.0% |
|
| Visual Disturbance |
100.0% |
|
| Secondary |
| Tuberculosis |
30.1% |
| Hiv Infection |
17.3% |
| Drug Use For Unknown Indication |
13.4% |
| Pulmonary Tuberculosis |
6.2% |
| Disseminated Tuberculosis |
4.5% |
| Prophylaxis |
3.7% |
| Antifungal Prophylaxis |
3.3% |
| Meningitis Aseptic |
3.1% |
| Product Used For Unknown Indication |
2.9% |
| Bone Tuberculosis |
1.8% |
| Maternal Exposure During Pregnancy |
1.8% |
| Antibiotic Prophylaxis |
1.7% |
| Lymph Node Tuberculosis |
1.4% |
| Meningitis Tuberculous |
1.4% |
| Renal Transplant |
1.4% |
| Hypertension |
1.3% |
| Insomnia |
1.3% |
| Maternal Exposure Timing Unspecified |
1.3% |
| Infection |
1.1% |
| Peritoneal Tuberculosis |
1.0% |
|
| Vomiting |
14.8% |
| Hepatitis Fulminant |
7.4% |
| Neutropenia |
7.4% |
| Immune Reconstitution Syndrome |
6.5% |
| Electroencephalogram Abnormal |
5.6% |
| Joint Effusion |
5.6% |
| Pancreatitis Acute |
5.6% |
| Pyrexia |
5.6% |
| Toxic Skin Eruption |
4.6% |
| Transaminases Increased |
4.6% |
| Hypoglycaemia |
3.7% |
| Jaundice |
3.7% |
| Rash |
3.7% |
| Rash Maculo-papular |
3.7% |
| Renal Failure Acute |
3.7% |
| Hepatitis Cholestatic |
2.8% |
| Nervous System Disorder |
2.8% |
| Renal Tubular Disorder |
2.8% |
| Thrombocytopenia |
2.8% |
| Tuberculosis Liver |
2.8% |
|
| Concomitant |
| Tuberculosis |
23.9% |
| Hiv Infection |
23.2% |
| Pulmonary Tuberculosis |
12.1% |
| Product Used For Unknown Indication |
7.7% |
| Drug Use For Unknown Indication |
4.9% |
| Prophylaxis |
4.4% |
| Mycobacterium Avium Complex Infection |
3.1% |
| Disseminated Tuberculosis |
2.5% |
| Acquired Immunodeficiency Syndrome |
2.4% |
| Rheumatoid Arthritis |
2.3% |
| Lymphoma |
1.8% |
| Anaemia |
1.7% |
| Antifungal Prophylaxis |
1.7% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Mycobacterial Infection |
1.3% |
| B-cell Lymphoma |
1.2% |
| Hypertension |
1.2% |
| Cytomegalovirus Infection |
1.1% |
| Lung Transplant |
1.1% |
| Pain |
1.1% |
|
| Pyrexia |
18.5% |
| Renal Failure |
9.2% |
| Tuberculosis |
9.2% |
| Renal Failure Acute |
8.4% |
| Vomiting |
7.6% |
| Clostridium Difficile Colitis |
5.0% |
| Subdural Haematoma |
5.0% |
| Hepatic Enzyme Increased |
4.2% |
| Urticaria |
4.2% |
| Drug Eruption |
3.4% |
| Viral Infection |
3.4% |
| Hepatic Failure |
2.5% |
| Hepatitis Fulminant |
2.5% |
| Impaired Gastric Emptying |
2.5% |
| Lymphadenopathy |
2.5% |
| Rash |
2.5% |
| Renal Tubular Necrosis |
2.5% |
| Splenomegaly |
2.5% |
| Vertigo |
2.5% |
| Cholestasis |
1.7% |
|
